General Announcement::Glenmark Pharmaceuticals launches Rufinamide Tablets

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
01-Jun-2021 13:19:01
Status
New
Announcement Sub Title
Glenmark Pharmaceuticals launches Rufinamide Tablets
Announcement Reference
SG210601OTHRIL73
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Limited
Designation
Company Secretary & Compliance Officer
Effective Date and Time of the event
01/06/2021 00:00:00
Description (Please provide a detailed description of the event in the box below)
Glenmark Pharmaceuticals launches Rufinamide Tablets USP, 200 mg and 400 mg

Attachments

SGX PR 01062021.pdf
Total size =965K